I have been informed that the Clinical Trial TAX 3501 has been closed
at all locations. This is a rather abrupt and premature termination of
the Trial. The Trial's basic purpose was to explore the simultaneous
administration of Eligard and Taxotere. The potential for significant
information useful to many of us was significant.

I have been unable to find out why this trial was closed. No one seems
willing to talk about it!

Does anyone have any conections which could be used to find out the
reason for closing?

The Trial was entitled: XRP6976J/3501. ClinicalTrials.gov Identifier:
NCT00283062 The ClinicalTrials.gov website lists this trial as ongoing
but not recruiting - apparently they have not received word of its
closing.

Any leads at all would be appreciated!